Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study()

There is a strong scientific rationale to use nebulised unfractionated heparin (UFH) in treating patients with COVID-19. This pilot study investigated whether nebulised UFH was safe and had any impact on mortality, length of hospitalisation and clinical progression, in the treatment of hospitalised...

Descripción completa

Detalles Bibliográficos
Autores principales: DeNucci, Gilberto, Wilkinson, Tom, Sverdloff, Carlos, Babadopulos, Tainah, Woodcock, Ashley, Shute, Jan, Renato Guazelli, Pedro, Gerbase, Luis Frederico, Mourão, Paulo A.S., Singh, Dave, van Haren, Frank M.P., Page, Clive
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064078/
https://www.ncbi.nlm.nih.gov/pubmed/36990381
http://dx.doi.org/10.1016/j.pupt.2023.102212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064078/
https://www.ncbi.nlm.nih.gov/pubmed/36990381
http://dx.doi.org/10.1016/j.pupt.2023.102212

Ejemplares similares